Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. It provides agents targeting the transforming growth factor-beta (TGF-beta) and epidermal growth factor receptor (EGFR) pathways.

TypeSubsidiary
Parent CompanyBristol-Myers Squibb
HQAustin, TX, US
Founded2011
Websiteforbius.com
Cybersecurity ratingAMore
Forbius was founded in 2011 and is headquartered in Austin, TX, US
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Forbius

Ilia Tikhomirov

Ilia Tikhomirov

President and CEO, Director

Forbius Office Locations

Forbius has offices in Austin and Montréal
Austin, TX, US (HQ)
701 Brazos St #930
Montréal, CA
101-750 Boul St-Laurent
Show all (2)

Forbius Financials and Metrics

Summary Metrics

Founding Date

2011
Forbius is a subsidiary of Bristol-Myers Squibb

Forbius Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Forbius Online and Social Media Presence

Embed Graph

Forbius News and Updates

Bristol Myers Squibb Completes Acquisition of Forbius

Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its transaction to acquire Forbius for their TGF-beta program, including its lead investigational asset AVID200, currently in Phase 1 for oncology and fibrosis

Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta Asset to Portfolio

Bristol Myers Squibb (NYSE: BMY) and Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases, today announced that they have entered into a definitive agreement under which Bristol Myers Squibb …

Forbius Completes Enrollment into Phase 1a Solid Tumor Trial of AVID200, First-in-Class TGF-beta 1 & 3 Inhibitor; Closes Series C Financing

Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced today that the Phase 1a solid tumor trial exploring the safety and tolerability of AVID200, a first-in-class TGF-beta 1 & 3 selective inhibitor, administered as a monothera…

Forbius Frequently Asked Questions

  • When was Forbius founded?

    Forbius was founded in 2011.

  • Who are Forbius key executives?

    Forbius's key executives are Ilia Tikhomirov.

  • How many employees does Forbius have?

    Forbius has 13 employees.

  • Who are Forbius competitors?

    Competitors of Forbius include CytomX Therapeutics, Agios Pharmaceuticals and Bolt Biotherapeutics.

  • Where is Forbius headquarters?

    Forbius headquarters is located at 701 Brazos St #930, Austin.

  • Where are Forbius offices?

    Forbius has offices in Austin and Montréal.

  • How many offices does Forbius have?

    Forbius has 2 offices.